BRNS:NASDAQ
Barinthus Biotherapeutics PLC - ADR
$0.72
arrow_downward
-3.18%(-0.024) 1D
Sep 3, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BRNS...
Open
$0.72
High
$0.74
Low
$0.70
Mkt. cap
29.51M
Avg. vol.
51.22K
Volume
37.84K
52-wk high
$1.83
52-wk low
$0.51
EPS
-$1.02
Beta
-0.37
Shares outstanding
40.85M
No. of employees
14
Open
$0.72
High
$0.74
Low
$0.70
Mkt. cap
29.51M
Avg. vol.
51.22K
Volume
37.84K
52-wk high
$1.83
52-wk low
$0.51
EPS
-$1.02
Beta
-0.37
Shares outstanding
40.85M
No. of employees
14
News stories
From web sources and news partners
Simply Wall Street
·
1 day ago
Uncovering Promising Penny Stocks In September 2026
TipRanks
·
2 days ago
Barinthus Biotherapeutics advances court-approved merger, Nasdaq exit
Profile
Barinthus Biotherapeutics plc is a biotechnology company developing immunotherapies for infectious diseases, cancer and autoimmune diseases such as hepatitis B, HPV and prostate cancer. Formerly known as Vaccitech plc, in November 2023 the company announced that it had renamed itself to Barinthus Biotherapeutics plc. As of 2024, the company employs more than 100 people. Wikipedia
About Barinthus Biotherapeutics PLC - ADR